Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

The 3-year overall survival rates for each group were 83.1% for the MSD-ASCT group, 85.7% for the auto-HSCT group, and 70.4% for the chemotherapy group. For patients with acute myeloid leukemia ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

The use of medical cannabis or marijuana for managing cancer-related symptoms such as pain, appetite loss and nausea has long ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The discovery broadens the known spectrum of this rare disorder, emphasizing the critical role of collaboration with patient ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

Uterine carcinosarcoma, also referred to as malignant mixed Müllerian tumor, is a rare and highly aggressive neoplasm predominantly affecting postmenopausal women. Combining carcinomatous and ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

The US government recommends giving hydroxyurea to children with severe sickle cell disease starting at 9 to 12 months old. Although hydroxyurea was first used as a chemotherapy drug, it has been used ...